Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Case Comprehensive Cancer Center
- Study ID
- NCT06811454
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cancer
- Depression
- Stage I Breast Cancer
- Stage I Colorectal Cancer
- Stage I Prostate Cancer
- Stage II Breast Cancer
- Stage II Colorectal Cancer
- Stage II Prostate Cancer
- Stage III Breast Cancer
- Stage III Colorectal Cancer
- Stage III Prostate Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MINDSET — BEHAVIORALParticipants randomized to MINDSET will receive a text message at their preferred time each day for 8 weeks containing a link to the 15-minute audio content. At the end of each week (on day 7), participants will receive a second link to the weekly survey in the text. Participants will be able to play the audio content on their device by clicking the first link and access the weekly survey by clicking the second.
- Enhanced Usual Care (EUC) — BEHAVIORALParticipants will receive a 1-page brochure summarizing publicly available information on depression self-care strategies via text each week for 8 weeks on the same day they receive the text message containing a link to the weekly survey (day 7). This information will come from the Facing Forward: Life After Cancer Treatment booklet from the National Cancer Institute.38 Weekly topics will include: 1) Reducing stress; 2) Coping with stress; 3) Coping with depression; 4) Feeling angry; 5) Feeling alone; 6) Finding meaning after treatment; 7) Social relationships; and 8) Seeking support. These materials do not include any content on mindfulness or cognitive therapy.
Study Details
The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.
Key Dates
- Start date
- Aug 3, 2026
- Status verified
- Jan 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 76 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ARM 1Participants will be randomized to MINDSET
- Other: ARM 2Participants will be randomized to EUC
Primary Outcome Measure
Feasibility as assessed by listening rate [ Time Frame: 12 weeks ]
Central Contacts
- Narissa McCarty, MS(216) 780-1931
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Case Comprehensive Cancer Center, Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Chelsea Siwik, PhD Chelsea Siwik, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cleveland, OH
By condition
By specialty
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Precision Cancer Medicine for Advanced Cancer Through High-throughput SequencingRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama